The pathogen that causes the sexually transmitted disease gonorrhea is notorious for its ability to develop drug resistance. But now there are two more treatment options. In December, the U.S. Food ...
The U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea. The first approval is for Nuzolvence (zoliflodacin) granules that ...
For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...
What Is Nuzolvence, and Why Does It Matter? Nuzolvence (zoliflodacin) is a new oral antibiotic approved by the FDA to treat uncomplicated gonorrhea of the urinary and genital tract. It is meant for ...
Dec 12 (Reuters) - The U.S. health regulator on Friday approved Innoviva's (INVA.O), opens new tab oral antibiotic to treat gonorrhea, a common sexually transmitted infection, offering patients an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results